Open AccessMedication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis
Author(s) -
Shari S. Rogal,
Ada O. Youk,
Olufunso Agbalajobi,
Hongwei Zhang,
Walid F. Gellad,
Michael J. Fine,
Pamela S. Belperio,
Timothy R. Morgan,
Chester B. Good,
Kevin L. Kraemer
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001228
Subject(s) - medicine , opioid use disorder , cirrhosis , methadone , cohort , buprenorphine , population , odds ratio , veterans affairs , confidence interval , hepatitis c , medical prescription , decompensation , cohort study , psychiatry , opioid , environmental health , receptor , pharmacology
Although opioid use disorder (OUD) is common in patients with cirrhosis, it is unclear how medication treatment for OUD (MOUD) is used in this population. We aimed to assess the factors associated with MOUD and mortality in a cohort of Veterans with cirrhosis and OUD.